28.08.17: Events: Xarelto COMPASS Data at ESC Congress 2017

Events: Xarelto COMPASS Data at ESC Congress 2017Full data from the Phase III COMPASS Study with Xarelto (Rivaroxaban) have been featured in Hot Line presentations at ESC Congress 2017 on August 27, 2017 in Barcelona, Spain. On this occasion we will host a conference call for investors and analysts today, starting at ap-prox. 1:30 p.m. CEST (11:30 a.m. UTC).Link to websiteAll changes
Source: Bayer IR Newsfeed: New on this site - Category: Pharmaceuticals Source Type: news